Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Organic Letters
|
July 5, 2012
Ni-catalyzed alkenylation of triazolopyridines: synthesis of 2,6-disubstituted pyridines
Sheng Liu, James Sawicki, Tom G Driver
ACS Medicinal Chemistry Letters
|
June 14, 2023
Recent Developments in Mass Spectrometry to Support Next-Generation Synthesis and Screening
Nari N Talaty, Robert W Johnson, James Sawicki, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 27, 2022
Optimization of Zebrafish Larvae Sectioning for Mass Spectrometry Imaging
Junhai Yang, Lauren Rendino, Steven Cassar, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 27, 2022
Evaluation of Quantitative Platforms for Single Target Mass Spectrometry Imaging
Andrew P Bowman, James Sawicki, Nari N Talaty, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 21, 2016
Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites
Hong Liu, Melissa J Michmerhuizen, Yanbin Lao, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Organic Letters
|
July 5, 2012
Ni-catalyzed alkenylation of triazolopyridines: synthesis of 2,6-disubstituted pyridines
Sheng Liu, James Sawicki, Tom G Driver
ACS Medicinal Chemistry Letters
|
June 14, 2023
Recent Developments in Mass Spectrometry to Support Next-Generation Synthesis and Screening
Nari N Talaty, Robert W Johnson, James Sawicki, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 27, 2022
Optimization of Zebrafish Larvae Sectioning for Mass Spectrometry Imaging
Junhai Yang, Lauren Rendino, Steven Cassar, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 27, 2022
Evaluation of Quantitative Platforms for Single Target Mass Spectrometry Imaging
Andrew P Bowman, James Sawicki, Nari N Talaty, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 21, 2016
Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites
Hong Liu, Melissa J Michmerhuizen, Yanbin Lao, et al.
Page
of 1